PRAX (STOCKS)
Praxis Precision Medicines, Inc. Common Stock
$264.540000
-2.040000 (-0.77%)
Prev close: $266.580000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Marcio Souza
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $7,366.69M
- Employees
- 82
- P/E (TTM)
- -19.77
- P/B (TTM)
- 5.27
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
9
Strong Buy
11
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-3.20 | $-3.62 | +0.4202 | +11.61% |
|
Dec 2025 (Q4)
|
$-3.50 | $-3.16 | -0.3375 | -10.67% |
|
Sep 2025 (Q3)
|
$-3.36 | $-3.51 | +0.1509 | +4.30% |
|
Jun 2025 (Q2)
|
$-3.31 | $-3.40 | +0.0874 | +2.57% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $30.80M |
| Operating Expenses | $357.33M |
| Research and Development | $284.30M |
| Other Operating Expenses | $73.03M |
| Operating Income/Loss | -$357.33M |
| Income/Loss From Continuing Operations After Tax | -$326.53M |
| Income/Loss From Continuing Operations Before Tax | -$326.06M |
| Net Income/Loss | -$326.53M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$326.53M |
| Net Income/Loss Available To Common Stockholders, Basic | -$326.53M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$13.38 |
| Diluted Earnings Per Share | -$13.38 |
| Basic Average Shares | 73,334,346 |
| Diluted Average Shares | 73,334,346 |
| Assets | $1.46B |
| Current Assets | $797.77M |
| Cash | $1.40B |
| Noncurrent Assets | $662.43M |
| Fixed Assets | $170.00K |
| Other Non-current Assets | $662.26M |
| Liabilities | $50.24M |
| Current Liabilities | $50.24M |
| Accounts Payable | $31.16M |
| Other Current Liabilities | $19.08M |
| Noncurrent Liabilities | $0.00 |
| Equity | $1.41B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.41B |
| Liabilities And Equity | $1.46B |
| Net Cash Flow From Operating Activities | -$282.21M |
| Net Cash Flow From Operating Activities, Continuing | -$282.21M |
| Net Cash Flow From Investing Activities | -$604.36M |
| Net Cash Flow From Investing Activities, Continuing | -$604.36M |
| Net Cash Flow From Financing Activities | $1.26B |
| Net Cash Flow From Financing Activities, Continuing | $1.26B |
| Net Cash Flow | $370.77M |
| Net Cash Flow, Continuing | $370.77M |
| Comprehensive Income/Loss | -$328.52M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$328.79M |
| Other Comprehensive Income/Loss | -$257.40M |